flutamide has been researched along with acid phosphatase in 22 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (40.91) | 18.7374 |
1990's | 10 (45.45) | 18.2507 |
2000's | 3 (13.64) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Munshi, SR; Nagendranath, N; Raman, G; Sheth, AR | 1 |
Müntzing, J; Murphy, GP; Myhrberg, H; Sandberg, AA; Saroff, J | 1 |
Kastelan, M; Kraljić, I; Tarle, M | 1 |
Fosså, SD; Hosbach, G; Paus, E | 1 |
Radoś, N; Tarle, M | 1 |
Schulze, H; Senge, T | 1 |
Belanger, A; Bergeron, V; Dupont, A; Emond, J; Giguere, M; Labrie, F; Lacoursiere, Y; Monfette, G | 1 |
Cunningham, GR; Kong, AY; Shao, TC | 1 |
Belanger, A; Bergeron, N; Borsanyi, JP; Cusan, L; Dupont, A; Emond, J; Giguere, M; Labrie, F; Lacourciere, Y | 1 |
Belanger, A; Dupont, A; Labrie, F; Lachance, R | 1 |
Albert, J; Geller, J; Geller, S; Loza, D; Nachtsheim, DA | 1 |
Sogani, PC; Vagaiwala, MR; Whitmore, WF | 1 |
Coffey, DS; Isaacs, JT; Scott, WW; Weissman, RM | 1 |
Cusan, L; Diamond, P; Dupont, A; Gomez, JL; Labrie, F; Lemay, M; Moore, S | 1 |
Baert, LV; Elgamal, AA; Lauweryns, JM; Van de Voorde, WM; Van Poppel, HP; Verbeken, EK | 1 |
Battaglia, M; Boccardo, F; Decensi, A; Giuliani, L; Guarneri, D; Martorana, G; Oneto, F; Pace, M; Rubagotti, A; Selvaggi, F | 1 |
Alvarez Kindelan, J; Leva Vallejo, M; Merchan García, JA; Prieto Castro, R; Regueiro López, JC; Requena Tapia, MJ; Ruiz Alvarez Cienfuegos, F | 1 |
Judd, J; Kremer, M; Oursler, MJ; Pascoe, D; Pederson, L; Riggs, BL; Spelsberg, TC | 1 |
Granter, SR; Renshaw, AA | 1 |
Bechev, R; Chakarov, S; Fachikov, Ts; Lazarov, Z; Rangelov, S | 1 |
Härkönen, PL; Hentunen, TA; Michael, H; Väänänen, HK | 1 |
Corradi, LS; Góes, RM; Leite Vilamaior, PS; Oliveira, SM; Taboga, SR | 1 |
5 trial(s) available for flutamide and acid phosphatase
Article | Year |
---|---|
Flutamide in hormone-resistant prostatic cancer.
Topics: Acid Phosphatase; Aged; Antigens, Neoplasm; Biomarkers, Tumor; Drug Evaluation; Flutamide; Humans; Male; Prostate-Specific Antigen; Prostatic Neoplasms | 1990 |
Combination therapy with flutamide and castration (LHRH agonist or orchiectomy) in advanced prostate cancer: a marked improvement in response and survival.
Topics: Acid Phosphatase; Anilides; Bone and Bones; Bone Neoplasms; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Drug Therapy, Combination; Flutamide; Gonadotropin-Releasing Hormone; Humans; Male; Orchiectomy; Prostatic Neoplasms; Radionuclide Imaging; Testosterone | 1985 |
Experience with flutamide in patients with advanced prostatic cancer without prior endocrine therapy.
Topics: Acid Phosphatase; Adenocarcinoma; Adult; Aged; Anilides; Bone Neoplasms; Clinical Trials as Topic; Flutamide; Humans; Hydronephrosis; Male; Middle Aged; Prostatic Neoplasms; Soft Tissue Neoplasms; Urination Disorders | 1984 |
Goserelin acetate with or without flutamide in the treatment of patients with locally advanced or metastatic prostate cancer. The Italian Prostatic Cancer Project (PONCAP) Study Group.
Topics: Acid Phosphatase; Aged; Aged, 80 and over; Flutamide; Goserelin; Humans; Male; Middle Aged; Prostatic Neoplasms; Time Factors | 1993 |
[Prognosis significance of prostatic markers in patients with prostatic adenocarcinoma undergoing total hormonal blockade].
Topics: Acid Phosphatase; Adenocarcinoma; Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Flutamide; Follow-Up Studies; Humans; Leuprolide; Male; Prognosis; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms | 1995 |
17 other study(ies) available for flutamide and acid phosphatase
Article | Year |
---|---|
Testicular phosphatase activity in rats treated with cyproterone acetate & flutamide.
Topics: Acid Phosphatase; Alkaline Phosphatase; Anilides; Animals; Cyproterone; Flutamide; Male; Rats; Testis | 1977 |
Histochemical and ultrastructural study of prostatic tissue from baboons treated with antiprostatic drugs.
Topics: Acid Phosphatase; Aminopeptidases; Anilides; Animals; Atrophy; Diethylstilbestrol; Epithelial Cells; Epithelium; Estramustine; Flutamide; Glucuronidase; Haplorhini; Humans; Male; Nitrogen Mustard Compounds; Papio; Prostate; Prostatic Neoplasms | 1976 |
NK cell activity in treated prostate cancer patients as a probe for circulating tumor cells: hormone regulatory effects in vivo.
Topics: Acid Phosphatase; Antineoplastic Agents; Biomarkers, Tumor; Cyproterone Acetate; Cytotoxicity Tests, Immunologic; Cytotoxicity, Immunologic; Diethylstilbestrol; Estradiol; Estramustine; Flutamide; Hormones; Humans; Hydrocortisone; Killer Cells, Natural; Male; Orchiectomy; Prolactin; Prostate-Specific Antigen; Prostatic Neoplasms; Radioimmunoassay; Testosterone | 1992 |
Investigation on serum neurone-specific enolase in prostate cancer diagnosis and monitoring: comparative study of a multiple tumor marker assay.
Topics: Acid Phosphatase; Antigens, Neoplasm; Antineoplastic Agents; APUD Cells; Biomarkers, Tumor; Carcinoembryonic Antigen; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Estramustine; Flutamide; Humans; Male; Orchiectomy; Phosphopyruvate Hydratase; Prostate-Specific Antigen; Prostatic Neoplasms | 1991 |
Influence of different types of antiandrogens on luteinizing hormone-releasing hormone analogue-induced testosterone surge in patients with metastatic carcinoma of the prostate.
Topics: Acid Phosphatase; Aged; Androgen Antagonists; Buserelin; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Flutamide; Goserelin; Humans; Luteinizing Hormone; Male; Premedication; Prostatic Neoplasms; Testosterone; Time Factors | 1990 |
Acid phosphatase activity: a marker of androgen action in prostate explant cultures.
Topics: Acid Phosphatase; Animals; Cells, Cultured; Cyproterone; Cyproterone Acetate; Dihydrotestosterone; Dose-Response Relationship, Drug; Estradiol; Flutamide; Hydrocortisone; Male; Prostate; Rats; Rats, Inbred Strains | 1987 |
Combination therapy with flutamide and [D-Trp6]LHRH ethylamide for stage C prostatic carcinoma.
Topics: Acid Phosphatase; Adenocarcinoma; Adrenal Cortex Hormones; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Delayed-Action Preparations; Flutamide; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Humans; Male; Middle Aged; Neoplasm Staging; Prostatic Neoplasms; Testosterone; Triptorelin Pamoate | 1988 |
Flutamide eliminates the risk of disease flare in prostatic cancer patients treated with a luteinizing hormone-releasing hormone agonist.
Topics: Acid Phosphatase; Aged; Anilides; Drug Therapy, Combination; Flutamide; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Male; Prostatic Neoplasms; Testosterone; Triptorelin Pamoate | 1987 |
The effects of flutamide on total DHT and nuclear DHT levels in the human prostate.
Topics: Acid Phosphatase; Administration, Oral; Anilides; Cell Nucleus; Dihydrotestosterone; Flutamide; Humans; Male; Prostate; Prostatic Hyperplasia; Testosterone | 1981 |
Concepts in prostatic cancer biology: Dunning R-3327 H, HI, and AT tumors.
Topics: Acid Phosphatase; Adenocarcinoma; Animals; Castration; Diethylstilbestrol; Disease Models, Animal; Flutamide; Male; Neoplasm Metastasis; Prostatic Neoplasms; Rats; Steroids; Testosterone | 1980 |
Metastatic prostate cancer pulmonary nodules: beneficial effects of combination therapy and subsequent withdrawal of flutamide.
Topics: Acid Phosphatase; Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bone and Bones; Flutamide; Gonadotropin-Releasing Hormone; Humans; Lung Neoplasms; Male; Middle Aged; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radionuclide Imaging; Sputum; Tomography, X-Ray Computed; Triptorelin Pamoate | 1994 |
Morphologic and immunohistochemical changes in prostate cancer after preoperative hormonal therapy. A comparative study of radical prostatectomies.
Topics: Acid Phosphatase; Adenocarcinoma; Aged; Chemotherapy, Adjuvant; Chromogranin A; Chromogranins; Estramustine; Flutamide; Humans; Immunohistochemistry; Male; Mitosis; Neoplasm Staging; Premedication; Proliferating Cell Nuclear Antigen; Prostate; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms | 1994 |
Androgens regulate bone resorption activity of isolated osteoclasts in vitro.
Topics: Acid Phosphatase; Androgen Antagonists; Androgens; Animals; Bone Resorption; Cathepsin B; Chickens; Dihydrotestosterone; Flutamide; Genes, Reporter; Humans; Isoenzymes; Metribolone; Mice; Osteoclasts; Receptors, Androgen; Regulatory Sequences, Nucleic Acid; Tartrate-Resistant Acid Phosphatase; Transfection; Transforming Growth Factor beta | 1999 |
Metastatic, sarcomatoid, and PSA- and PAP-negative prostatic carcinoma: diagnosis by fine-needle aspiration.
Topics: Acid Phosphatase; Adenocarcinoma; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carcinoembryonic Antigen; Flutamide; Humans; Immunohistochemistry; Keratins; Leuprolide; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Sarcoma | 2000 |
[Radical prostatectomy with broadened scope of indications - analysis of early experience].
Topics: Acid Phosphatase; Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Biopsy; Flutamide; Goserelin; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms | 1999 |
Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
Topics: Acid Phosphatase; Adult; Androgen Antagonists; Animals; Bone Resorption; Carrier Proteins; Cattle; Cell Differentiation; Cell Line, Tumor; Coculture Techniques; Dexamethasone; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrogens; Flutamide; Fulvestrant; Glycoproteins; Humans; Isoenzymes; Lipopolysaccharide Receptors; Macrophage Colony-Stimulating Factor; Male; Membrane Glycoproteins; Monocytes; Osteoclasts; Osteoprotegerin; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Tartrate-Resistant Acid Phosphatase; Testosterone; Tumor Necrosis Factor-alpha | 2005 |
Cellular and extracellular behavior in the gerbil (Meriones unguiculatus) ventral prostate following different types of castration and the consequences of testosterone replacement.
Topics: Acid Phosphatase; Androgen Antagonists; Animals; Cyproterone; Disease Models, Animal; Endoplasmic Reticulum, Rough; Endothelium; Flutamide; Gerbillinae; Immunohistochemistry; Male; Microscopy, Electron, Transmission; Orchiectomy; Organ Size; Prostate; Prostatic Hyperplasia; Protein Tyrosine Phosphatases; Receptors, Androgen; Testosterone | 2007 |